Erin McEvoy

On June 14–15, Natoli Engineering Company, a manufacturer of tablet compression tooling, is offering hands-on training on how to sharpen skills in tablet press setup, operation, and maintenance procedures.

Dr. Uwe Blesching provides insight into the exploration of cannabis as a supplement for chronic pain treatment, opioid addiction mitigation, and the mind-body balance.

Cannabis Science Conference West, taking place May 18-20 in Long Beach, California, is quickly approaching. The two-day agenda is packed with exciting speakers from around the country. In this preview, we hear from Dr. Tony Francis, Principal, SAW Environmental. Dr. Francis is also an IAS instructor and assessor and a fully qualified National Environmental Laboratories Accreditation Conference (NELAC) assessor in organic and inorganic chemistry, microbiology, cryptosporidium, radiochemistry, solids, aqueous, tissue, and air. Here he shares some insights into his talk, “Importance of Quality Control in Cannabis Laboratories,” scheduled for Friday, May 20 from 9:30 – 10:00 am. We hope to see you there!

Medicare Plans, a patient support center that provides resources for better understanding Medicare, recently conducted a survey about the idea of Medicare coverage for medical cannabis treatment and products. Here are some highlights from their results.

The United Kingdom (UK), the first country to formally regulate the market for consumer cannabinoid products, recently released a list of cannabinoid product legally permitted for sale.

Cannabidiol (CBD) has been a hot topic for several years now and it seems like you can buy CBD almost anywhere. As a consumer, how do you know that the CBD at your local drug store is the same quality at a cannabis or hemp retail store? Education is key to knowing the difference and finding a top-notch product. In this interview, Vince Sanders, founder and president of CBD American Shaman, discusses his company’s approach to cannabis retail, their main motivators for success, and his plans for continual expansion in the cannabis industry.

ASA has local chapters throughout the United States and in this new series of interviews, we will be introducing you to those chapters and highlighting some of the state-level work being done to advocate for patient’s access and rights. In our first installment, we introduce the Bay Area ASA chapter.

What more needs to be done for patient rights, protections, and access to cannabis in the United States? In this interview, Abbey Roudebush, Director of Government Affairs for Americans for Safe Access (ASA), explains the goals of ASA and provides an in-depth analysis of their annual State of the States report. She explains why medical cannabis access is a pertinent issue, the myriad obstacles patients still face in securing protections, and how to advocate for the rights of medical cannabis patients.

Scheril Murray Powell, Esq., shares a preview of her talk “International Cannabis: Trade and Supply Chain Considerations for a Global Cannabis Brand.”

A new commission for the United Kingdom (UK), the Hodges Review of UK Public Policy and Regulatory Stewardship of the Legal Cannabis Industry, will analyze its current legal cannabis industry and make recommendations on how to best maximize its growth, consumer satisfaction, and competitive potential on a global scale.

The cannabis industry continues to step up and help raise money for humanitarian efforts in support of Ukraine.

The Veterans Action Council (VAC) recently sent US Attorney General Merrick Garland a request to remove cannabis from the federal controlled substances list.

In February, Senate Majority Leader Chuck Schumer explained in a press conference and in a letter to colleagues the details of his bill to federally legalize cannabis and announced his plan to introduce it in the coming weeks.

A dispensary in San Francisco, CA, joined with nearly two dozen cannabis brands, will donate proceeds starting on March 6 to support humanitarian aid in Ukraine.

Americans for Safe Access’s (ASA) State of the States report evaluates each state cannabis program from a patient perspective and assigns a grade that reflects patient rights and access to medical cannabis. ASA has released the report annually since 2014 and included two new core categories in the rubric for 2021. This year marks 25 years since the first implementation of a state cannabis law in the US and 20 years since ASA began working with state officials on medical cannabis laws.

The National Football League (NFL) is awarding $1 million in research funding to two teams of medical researchers to study the effects of cannabinoids on pain management and neuroprotection from concussion in elite football players.

One of the largest companies in the world—Apple—quietly changed its policy regarding apps that handle the sale and delivery of cannabis.

MJH Life Sciences™ announces the acquisition of the Cannabis Science Conference, which hosts the world's largest and most technical scientific and medical cannabis events and is aimed at improving cannabis science and education.

Cannabis Science and Technology® is pleased to announce the addition of André Silva, MSc Forensic Science to its editorial advisory board (EAB).

The Cannabis Authenticity and Purity Standard (CAPS) announced Kim Stuck, founder of Allay Consulting, LLC, as its first certified cannabis and hemp consultant in the US.

Register now for a virtual symposium with presentations on Building a Cannabis Lab, Product Safety, Product Quality, Best Practices and Advanced Topics, and an interactive Certificate-Based Cannabis Testing Master Class session.

Endosane Pharmaceuticals and the University of California Irvine agree to conduct a set of studies to investigate the efficacy of new compounds for the treatment of PTSD.

Royal Emerald Pharmaceuticals, a leading cannabis pharmaceutical company, announced it has received four licenses from the DEA to grow, research, develop, and manufacture alternative drugs derived from cannabis and other botanicals.

Yissum, the Technology Transfer Company at Hebrew University of Jerusalem as well as the university's Multidisciplinary Center for Cannabinoid Research (MCCR) recently announced a new partnership with TechforCann Europe Accelerator to strengthen the medical cannabis industry in Europe.